| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | President And CEO | Director, 10% Owner +2 more
2 companies
McCormack Riley is a 10% Owner at Oruka Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 6 sells.
Estimated insider holdings value: $207.7M based on current market prices.